Skip to main content
SpringerLink
Log in

Morbus Parkinson und Sexualität

  • Conference paper
Morbus Parkinson

Zusammenfassung

Die Parkinsonkrantkheit geh00F6;rt zu den h00E4;figen neurodegenerativen Erkrankungen. Die Pravalenz der Erkr00E4;nkung wird f00FC;r Mittel- und Nordeuropa mit ca. 160 pro 100.000 angegeben. Die Erkrankungshaufigkeit nimmt mit dem Alter zu. Die Pravalenz bei den 00FC;ber 60-j00E4;hrigen liegt bei ca. 1% bei den 00FC;ber 80-jahrigen gegen 3%. M00E4;nner und Frauen sind etwa gleich h00E4;ufig betroffen. Das Erkrankungsalter liegt in 10% der Falle vor dem 40. Lebensjahr, 40% der Patienten erkranken zwischen dem 50. und 60. Lebensjahr. Man geht davon aus, dass in Deutschland ca. 250.000 Menschen an der Parkinsonkrankheit leiden [8,30].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anderson KE (2001) Pharmacology of penile erection. Pharmacological reviews. 53: 417–450

    Google Scholar 

  2. Beier KM (2000) Sexualitat und Partnerschaft. Leitfaden fur Betroffene und ihre Partner. Pairdata GmbH, Potsdam-Babelsberg, S 7–56

    Google Scholar 

  3. Brock B, Bochinski D (2001) Modern pharmacotherapy for erectile dysfunction: evolving concepts with central and peripheral acting agents. Current Opinion in Urology 11: 625–630

    Article  PubMed  CAS  Google Scholar 

  4. Brockhaus (2000) Bibliographisches Institut, Mannheim

    Google Scholar 

  5. Brown RG, Jahanshahi M, Quinn N, Marsden CD (1990) Sexual function in patients with Parkinson’s disease and their partners. J Neurol Neurosurg Psychiatry 53: 480–486

    Article  CAS  Google Scholar 

  6. Feldmann HA, Goldstein I, Hatzichristou DG et al. (1994) Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 151: 54–61

    Google Scholar 

  7. Freud S (1990) Trieblehre. In: Freud S (Hrsg) Abriss der Psychoanalyse. Fischer, Frankfurt am Main, S 44–47

    Google Scholar 

  8. Gerlach M, Reichmann H, Riederer P (2001) Die Parkinsonkrankheit, Grundlagen, Klinik, Therapie. Springer, Wien, S 24–81

    Google Scholar 

  9. Graf KJ, Kiirten I (1983) Effects of dopamine agonists on prolactin, growth hormone, and cortisol secretion in animals and humans. In: Caine D, Horowski R, McDonald R, Wuttke W (eds) Lisuride and Other Dopamine Agonists. Raven Press, New York, pp 199–229

    Google Scholar 

  10. Guiliano F, Allard J (2001) Dopamine and male sexual function. European Urology 40: 601–608

    Article  Google Scholar 

  11. Guiliano F, Allard J (2002) Apomorphine SA: Preclinical and clinical experiences learned form the first central nervous system-acting ED drug. Int J Impot Res 14: 53–56

    Article  Google Scholar 

  12. Heaton JP (2000) Central neuropharmacological agents and mechanisms in erectile dysfunction: The role of dopamine. Neurosci Biobehav Res 24: 561–569

    Article  CAS  Google Scholar 

  13. Heinz A (1999) Anhedonienosologieiibergreifendes Korrelat einer Dysfunktion des dopaminergen Verstarkungssystems. Nervenarzt 5: 391–397

    Article  Google Scholar 

  14. Hilz, MJ, Hecht M, Kolsch C (2000) Erektile Dysfunktion. Aktuelle Neurologie 27: 1–12

    Article  Google Scholar 

  15. Horowski R (1983) Pharmacological effects of lisuride and their potential role in further research. In: Caine D, Horowski R, McDonald R, Wuttke W (eds) Lisuride and other dopamine agonists. Raven Press, New York, pp 127–139

    Google Scholar 

  16. Jost WH, Braune S (2001) Autonome Regulationsstorungen beim idiopathischen Parkinsonsyndrom. Aktuelle Neurologie 28, S 3: 235–241

    Google Scholar 

  17. Keller HH, Bonetti EP, Pieri L, Da Prada M (1983) Lisuride-induced mounting behavior and effects on the monoaminergic system in rat brain. In: Caine D, Horowski R, McDonald R, Wuttke W (eds) Lisuride and other dopamine agonists. Raven Press, New York, pp 79–87

    Google Scholar 

  18. Koller WC, Vetere-Overfield B, Williamson A, Busenbark K, Nash J, Parrish D (1990) Sexual dysfunction in Parkinson’s disease. Clin Neuropharmacol 5: 461–463

    Article  Google Scholar 

  19. Koulousakis A, Nittner K (1984) Parkinson’sche Erkrankung und Sexualfunktion. Vegetativstorungen beim Parkinsonsyndrom. In: 4. Frankfurter Parkinson-Symposium. Editiones Roche, Basel, S 189–208

    Google Scholar 

  20. Lambert D, Waters CH (1998) Sexual dysfunction in Parkinson’s disease. Clin Neurosci 5: 73–77

    Article  PubMed  CAS  Google Scholar 

  21. Lipe H, Longstreth WT Jr, Bird TD, Linde M (1990) Sexual function in married men with Parkinson’s disease compared to married men with arthritis. Neurology 40: 1347–1349

    Article  PubMed  CAS  Google Scholar 

  22. Marsden C (1990) Parkinson’s disease. Lancet 335: 948–952

    Article  PubMed  CAS  Google Scholar 

  23. Martignoni E, Pacchetti C, Micieli G, Nappi G (1995) Autonomic disturbances in Parkinson’s disease and Shy-Drager-Syndrome. In: Korczyn AD (ed) Handbook of Autonomic Nervous System Dysfunction. Dekker, New York, pp 237–252

    Google Scholar 

  24. Nehra A, Moreland RB (2001) Neurologic erectile dysfunction. Urol Clin North Am 28: 289–308

    Article  PubMed  CAS  Google Scholar 

  25. NIH consensus development panel on impotence (1993) 111.Impotence. JAMA 270: 83–90

    Google Scholar 

  26. Nusselt L, Stief CG (1997) Neuroanatomie der Sexualfunktion und Pathophysiologie der Sexualstorung. In: Stiihrer M, Madersbacher H, Palmtag H (Hrsg) Neurogene Blasenfunktionsstorung. Neurogene Sexualstorung. Springer, Berlin Heidelberg, S 267–274

    Chapter  Google Scholar 

  27. Okun MS, McDonald WM, DeLong MR (2002) Refractory nonmotor systems in male patients with Parkinson’s disease due to testosterone deficiency: a common unrecognized comorbidity. Arch Neurol 59: 807–811

    Article  PubMed  Google Scholar 

  28. Okun MS, Walter BJ, McDonald WM et al. (2002) Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson’s disease. Arch Neurol 59: 1750–1753

    Article  PubMed  Google Scholar 

  29. Peters HJ (1991) Neuroanatomie und Neurophysiologie des unteren Harntraktes. In: Madersbacher H, Palmtag H (Hrsg) Detrusorrelaxation. Grundlagen und klinische Aspekte. PVV-Verlag Preuss, Ratingen, S 16–27

    Google Scholar 

  30. Poewe W, Ceballos-Baumann 0, Conrad B (1996) Parkinsonkrankheit. In: Conrad B, Ceballos-Baumann 0 (Hrsg) Bewegungsstorungen in der Neurologie. Thieme, Stuttgart, S 30–67

    Google Scholar 

  31. Pomeranz SM (1992) Dopaminergic influences on male sexual behavoir of rhesus monkeys: Effecs of dopamine agonists. Pharmacol Biochem Behav 41: 511–517

    Article  Google Scholar 

  32. Raffaele R, Vecchio I, Giammusso B et al. (2002) Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson’s disease. Eur Urol 41: 382–386

    Article  PubMed  CAS  Google Scholar 

  33. Riederer P (1984) Das vegetative Nervensystem bei der Parkinsonkrankheit: Neurochemische Aspekte. Vegetativstorungen beim Parkinsonsyndrom. In: 4. Frankfurter Parkinson Symposium. Editiones Roche, Basel, S 63–73

    Google Scholar 

  34. Ruilope L, Garcia-Robles R, Paya C et al. (1983) Influence of Lisuride, a dopaminergic agonist, on the sexual function of male patients with chronic renal failure. Am J Kidney Dis 3: 182–185

    Google Scholar 

  35. Sakakibara R, Shinotoh H, Uchiyma T et al. (2001) Questonnaire-based assesment of pelvic organ dysfunction in Parkinson’s disease. Auton Neurosci 92: 76–85

    Article  PubMed  CAS  Google Scholar 

  36. Shabisgh R (2000) Recent developments in male sexual dysfunction. Curr Psychiatry Rep 2: 196–200

    Article  Google Scholar 

  37. Singer C (1995) Sexual dysfunction. In: Korczyn AD (ed) Handbook of autonomic nervous system dysfunction. Dekker, New York, pp 381–397

    Google Scholar 

  38. Singer C, Sanchez-Ramos J, Weiner WJ, Ackerman M (1989) Sexual dysfunction in parkinsonian males. Neurology: 145

    Google Scholar 

  39. Singer C, Weiner WJ, Sanchez-Ramos JR (1992) Autonomic dysfunction in men with Parkinson’s disease. Eur Neurol 32: 134–140

    Article  PubMed  CAS  Google Scholar 

  40. Weig W (2000) Die Rolle von Psychiatric und Psychotherapie in der Sexualmedizin nach der Markteinfiihrung von Viagra. Nervenarzt 3: 218–221

    Article  Google Scholar 

  41. Wein AJ, Walsh PC et al. (1998) Neuromuscular dysfunction of the lower urinary tract and its treatment. Campell’s Urology, 7th edn. WB Saunders, Philadelphia, pp 953–1006

    Google Scholar 

  42. Zahran AR, Simmermann N, Carrier S, Vachon P (2001) Erectile dysfunction occurs following substantia nigra lessons in the rat. Int J Impot Res 13: 255–260

    Article  PubMed  CAS  Google Scholar 

  43. Zesiewicz TA, Helal M, Hauser RA (2000) Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson’s disease. Mov Disord 15: 305–308

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. Hendrich
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik der Ruhr-Universität Bochum St. Josef-Hospital, Gudrunstraße 56, 44791, Bochum, Germany

    Horst Przuntek  & Thomas Müller  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hendrich, A. (2003). Morbus Parkinson und Sexualität. In: Przuntek, H., Müller, T. (eds) Morbus Parkinson. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57362-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57362-0_8

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-7985-1422-5

  • Online ISBN: 978-3-642-57362-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation